BioScreen - Human Clinical Testing Services

Clinical Safety Testing

• Human Repeat Insult Patch Test
  • HRIPT determines if a product may be sensitizing or irritating to the skin of the user
  • **Testing Available in Latin America**
  • Methods :
    • Draize Method
    • Shelanski Method
    • Marzulli and Maibach Method

• Primary Irritation Test
  • Products are applied·occlusively for a single 48-hour period
• Cumulative Irritation Test 
  • Products are applied occlusively for a period of 14 or 21 days to determine its irritancy potential
• Acnegenicity
• Comedogenicity
  • Method
    • Follicular Biopsy Method
    • Lesion Counting Method
• Acne Treatment
• Facial Stinging ("Safe for Sensitive Skin")

Ocular and Periocular Studies

Many of the industry`s most innovative and sophisticated test methodologies are conducted in BioScreen`s Ophthalmology department. Clinical studies for safety and efficacy are conducted on a diverse array of cosmetics, OTC, and pharmaceutical products. BioScreen specializes in industry standard tests for Ophthalmologic safety, or Ophthalmologist tested claims. Safety claim parameters may include, sensitive skin subjects and/or those that wear contact lenses. Common claims include ‘no-tears` or ‘does not sting eyes` for mild surfactant based products.

Types of Clinical Tests Performed

• Human Ocular Instillation
• No Sting/Non-Irritating Claims
• In-use Ophthalmic Safety Evaluations
• Ophthalmologist Tested